However, odds ratios were higher for omicron suggesting that booster doses are less protective than against delta
Remdesivir May Benefit Adults Early in COVID-19 Course
Real-world data support the use of remdesivir for hospitalized COVID-19 patients receiving no oxygen or low-flow oxygen
Thrombosis, Thrombocytopenia Syndrome Up After Ad26.COV2.S
Reporting rates 3.83 per million vaccine doses for Ad26.COV2.S versus 0.00855 per million for mRNA-based vaccines
Alterations in Gut Microbiome ID’d in Postacute COVID-19 Syndrome
Higher levels of Ruminococcus gnavus, Bacteroides vulgatus, lower levels of Faecalibacterium prausnitzii observed in patients with PACS
COVID-19 Vaccination Not Linked to Fecundability in Men, Women
SARS-CoV-2 infection associated with short-term transient decline in fertility for men
Omicron Linked to Increase in COVID-19 Cases, Lower Disease Severity
Mean length of stay and percentages admitted to ICU, receiving invasive mechanical ventilation, dying lower during omicron
Third mRNA Vaccine Dose Ups Effectiveness Against Hospitalization
Vaccine effectiveness against COVID-19 hospitalization increased with third dose in those with, without immunocompromising conditions
Scientists Watch, Worry About New ‘Stealth’ Version of Omicron Variant
The variant, called BA.2, has genetic traits that make it somewhat more difficult to detect
Hospital Defends Decision to Deny Heart Transplant to Unvaccinated Man
Other U.S. hospitals have also faced criticism for denying transplants to patients who were not vaccinated against COVID-19
Convalescent Plasma Benefits Certain COVID-19 Patients
Blood plasma donated by people who have recovered from COVID-19 may help hospitalized patients with the virus, a new study led by researchers at NYU Grossman School of Medicine indicates.
The peer-reviewed Original Investigation published by the JAMA Network on January 25, 2022, showed that among 2,341 patients, those who received an injection of convalescent plasma soon after hospitalization were 15% less likely to die within a month from COVID-19 than those who did not receive convalescent plasma or those who received an inactive saline placebo.